Artelo Biosciences (ARTL) Shares Outstanding (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Shares Outstanding (Entity) of $542194.0 for Q4 2025, up 968.34% year-over-year from $50751.0 in Q4 2024, and up 67.01% quarter-over-quarter from $324643.0 in Q3 2025.
Artelo Biosciences (ARTL) Shares Outstanding (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Shares Outstanding (Entity) for 12 consecutive years, with $542194.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 968.34% year-over-year to $542194.0; the TTM figure through Dec 2025 stood at $542194.0 (up 968.34% YoY), while the FY2025 annual figure was $542194.0, up 968.34% from the prior year.
- Shares Outstanding (Entity) advanced to $542194.0 in Q4 2025 per ARTL's latest filing, from $324643.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $112.8 million in Q4 2021 and bottomed at $50168.0 in Q3 2024.
- Historically, Shares Outstanding (Entity) has averaged $9.3 million across 5 years, with a median of $158653.0 in 2022.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 503599.34% — and 2025, when it sank 71.7%.
- Artelo Biosciences' Shares Outstanding (Entity) stood at $112.8 million in 2021, then tumbled by 99.86% to $158653.0 in 2022, then rose by 11.67% to $177168.0 in 2023, then slumped by 71.35% to $50751.0 in 2024, then soared by 968.34% to $542194.0 in 2025.
- Business Quant data shows ARTL's Shares Outstanding (Entity) at $542194.0 in Q4 2025, $324643.0 in Q3 2025, and $342907.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 157,255.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 542,194.00 |
| Sep 30, 2025 | 324,643.00 |
| Jun 30, 2025 | 342,907.00 |
| Mar 31, 2025 | 50,751.00 |
| Dec 31, 2024 | 50,751.00 |
| Sep 30, 2024 | 50,168.00 |
| Jun 30, 2024 | 179,337.00 |
| Mar 31, 2024 | 177,615.00 |
| Dec 31, 2023 | 164,448.00 |
| Sep 30, 2023 | 163,837.00 |
| Jun 30, 2023 | 158,670.00 |
| Mar 31, 2023 | 158,670.00 |
| Dec 31, 2022 | 157,392.00 |
| Sep 30, 2022 | 158,281.00 |
| Jun 30, 2022 | 157,255.00 |
| Mar 31, 2022 | 156,681.00 |
| Nov 30, 2021 | 112.75 Mn |
| Aug 31, 2021 | 69.17 Mn |
| May 31, 2021 | 85,602.00 |
| Feb 28, 2021 | 62,919.00 |